In serum-free conditions,an increase in apoptosis was detected in adherent CXCL12-expressing pancreatic cancer cells when compared with GFP-expressing controls, though this response was attenuated with the addition of serum (Fig. 8A–B). The gene discussed is CXCL12; the disease is pancreatic neoplasm.